About Matthew

Dr. Matthew Scheideman has developed expertise in various aspects of drug research and development from a decade of experience as a medicinal chemist in both the biotech and pharmaceutical industries. He strives to apply this firsthand experience by helping clients build and maintain robust patent portfolios in a number of therapeutic and technology areas. Matt’s practice includes drafting complex patent applications, prosecuting multi-jurisdictional patent applications, and assisting with freedom-to-operate, invalidity and patentability opinions.

View full bio

Experience

Sixth Street Invests in Blueprint Medicines

Sixth Street Invests in Blueprint Medicines

July 7, 2022

Cooley advised global investment firm Sixth Street on its strategic investment in Blueprint Medicines, a global precision therapy company that invents life-changing therapies for people with cancer and blood disorders. Lawyers Mischi a Marca, Matt Browne, Matt Scarano, Addison Pierce, Matt Kong and Nick Neuteufel led the Cooley team advising Sixth Street. 

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Matt Browne
Partner, San Diego
Matthew S. Scarano
Associate, San Diego
Addison Pierce
Partner, Chicago
Matt Kong
Associate, San Francisco
Dr. Michael Tuscan
Partner, Washington, DC
Dr. Jon Cousin
Partner, Washington, DC
Tanya Heare-Rowlands
Special Counsel, London
Jeffery Wyzykowski
Patent Agent, Washington, DC
Matthew Scheideman
Patent Agent, Washington, DC
Charity Williams
Partner, San Diego
Freddy Yip
Associate, Hong Kong
Zack Gong
Associate, Shanghai
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Michael Klein
Partner, New York
Paul Springer
Associate, New York
Megan Browdie
Partner, Washington, DC
Howard Morse
Senior Counsel, Washington, DC

Related Practices & Industries

Debt Finance
Private Equity
Life Sciences

Admissions and credentials

Registered to practice before the United States Patent and Trademark Office (USPTO)

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.